Vuong C, van Uum S, ODell L, Lutfy K, Friedman T
Endocr Rev. 2009; 31(1):98-132.
PMID: 19903933
PMC: 2852206.
DOI: 10.1210/er.2009-0009.
Shuster S, Riedl M, Li X, Vulchanova L, Elde R
J Neurosci. 1999; 19(7):2658-64.
PMID: 10087079
PMC: 6786082.
Soldo B, Moises H
J Physiol. 1998; 513 ( Pt 3):787-804.
PMID: 9824718
PMC: 2231325.
DOI: 10.1111/j.1469-7793.1998.787ba.x.
Rusin K, Giovannucci D, Stuenkel E, Moises H
J Neurosci. 1997; 17(17):6565-74.
PMID: 9254669
PMC: 6573146.
Pumford K, Russell J, Leng G
Exp Brain Res. 1993; 94(2):237-46.
PMID: 8395406
DOI: 10.1007/BF00230291.
Effects of the kappa-opioid agonist U50,488 on parturition in rats.
Douglas A, Clarke G, MacMillan S, Bull P, Neumann I, WAY S
Br J Pharmacol. 1993; 109(1):251-8.
PMID: 8388299
PMC: 2175571.
DOI: 10.1111/j.1476-5381.1993.tb13561.x.
Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.
Russell J, Coombes J, Leng G, Bicknell R
J Physiol. 1993; 469:365-86.
PMID: 8271202
PMC: 1143875.
DOI: 10.1113/jphysiol.1993.sp019818.
Gene expression and chemical diversity in hypothalamic neurosecretory neurons.
Meister B
Mol Neurobiol. 1993; 7(2):87-110.
PMID: 8103991
DOI: 10.1007/BF02935638.
Opiate binding differentially associated with oxytocin and vasopressin nerve endings from porcine neurohypophyses.
Falke N, Martin R
Exp Brain Res. 1988; 70(1):145-54.
PMID: 3402560
DOI: 10.1007/BF00271856.
Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin-releasing factor mRNA stimulation in the rat.
Lightman S, Young 3rd W
J Physiol. 1987; 394:23-39.
PMID: 2895179
PMC: 1191949.
DOI: 10.1113/jphysiol.1987.sp016858.
Coexisting peptides in hypothalamic neuroendocrine systems: some functional implications.
Bondy C, Whitnall M, Brady L, Gainer H
Cell Mol Neurobiol. 1989; 9(4):427-46.
PMID: 2575930
PMC: 11567416.
DOI: 10.1007/BF00712791.
Inhibition of elevated arginine vasopressin secretion in response to osmotic stimulation and acute haemorrhage by U-62066E, a kappa-opioid receptor agonist.
Yamada K, Nakano M, Yoshida S
Br J Pharmacol. 1990; 99(2):384-8.
PMID: 2158377
PMC: 1917399.
DOI: 10.1111/j.1476-5381.1990.tb14713.x.
Morphine actions on supraoptic oxytocin neurones in anaesthetized rats: tolerance after i.c.v. morphine infusion.
Pumford K, Leng G, Russell J
J Physiol. 1991; 440:437-54.
PMID: 1804971
PMC: 1180161.
DOI: 10.1113/jphysiol.1991.sp018717.
Naloxone potentiates the release of oxytocin induced by systemic administration of cholecystokinin without enhancing the electrical activity of supraoptic oxytocin neurones.
Leng G, Dyball R, WAY S
Exp Brain Res. 1992; 88(2):321-5.
PMID: 1577106
DOI: 10.1007/BF02259107.
Intracellular calcium and hormone release from nerve endings of the neurohypophysis in the presence of opioid agonists and antagonists.
Dayanithi G, Stuenkel E, Nordmann J
Exp Brain Res. 1992; 90(3):539-45.
PMID: 1358668
DOI: 10.1007/BF00230936.
Delta and kappa opiate receptors in primary astroglial cultures. Part II: Receptor sets in cultures from various brain regions and interactions with beta-receptor activated cyclic AMP.
Eriksson P, Hansson E, Ronnback L
Neurochem Res. 1992; 17(6):545-51.
PMID: 1318509
DOI: 10.1007/BF00968781.